Engineered T Cells Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: E6EB1AAB7AE6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Engineered T Cells in Global, including the following market information:

Global Engineered T Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Engineered T Cells market was valued at 270.8 million in 2021 and is projected to reach US$ 1308.3 million by 2028, at a CAGR of 25.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tumor Infiltrating Lymphocytes Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, Gilead Sciences, Juno Therapeutics, Novartis, Oxford Biomedica and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Engineered T Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Engineered T Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Engineered T Cells Market Segment Percentages, by Type, 2021 (%)

• Tumor Infiltrating Lymphocytes
• T Cell Receptor {TCR}
• Chimeric Antigen Receptor(CAR)

Global Engineered T Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Engineered T Cells Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cancer Research Centers
• Clinics

Global Engineered T Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Engineered T Cells Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Engineered T Cells revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Engineered T Cells revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Autolus Limited
• Bellicum Pharmaceuticals
• Cells Medica
• Elli Lilly and Company
• Gilead Sciences
• Juno Therapeutics
• Novartis
• Oxford Biomedica
• Pfizer
• Precision Bioscience
• Redmile Group
• Seeking Alpha
• Unum Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Engineered T Cells Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Engineered T Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENGINEERED T CELLS OVERALL MARKET SIZE

2.1 Global Engineered T Cells Market Size: 2021 VS 2028
2.2 Global Engineered T Cells Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Engineered T Cells Players in Global Market
3.2 Top Global Engineered T Cells Companies Ranked by Revenue
3.3 Global Engineered T Cells Revenue by Companies
3.4 Top 3 and Top 5 Engineered T Cells Companies in Global Market, by Revenue in 2021
3.5 Global Companies Engineered T Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Engineered T Cells Players in Global Market
  3.6.1 List of Global Tier 1 Engineered T Cells Companies
  3.6.2 List of Global Tier 2 and Tier 3 Engineered T Cells Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Engineered T Cells Market Size Markets, 2021 & 2028
  4.1.2 Tumor Infiltrating Lymphocytes
  4.1.3 T Cell Receptor {TCR}
  4.1.4 Chimeric Antigen Receptor(CAR)
4.2 By Type - Global Engineered T Cells Revenue & Forecasts
  4.2.1 By Type - Global Engineered T Cells Revenue, 2017-2022
  4.2.2 By Type - Global Engineered T Cells Revenue, 2023-2028
  4.2.3 By Type - Global Engineered T Cells Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Engineered T Cells Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Cancer Research Centers
  5.1.4 Clinics
5.2 By Application - Global Engineered T Cells Revenue & Forecasts
  5.2.1 By Application - Global Engineered T Cells Revenue, 2017-2022
  5.2.2 By Application - Global Engineered T Cells Revenue, 2023-2028
  5.2.3 By Application - Global Engineered T Cells Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Engineered T Cells Market Size, 2021 & 2028
6.2 By Region - Global Engineered T Cells Revenue & Forecasts
  6.2.1 By Region - Global Engineered T Cells Revenue, 2017-2022
  6.2.2 By Region - Global Engineered T Cells Revenue, 2023-2028
  6.2.3 By Region - Global Engineered T Cells Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Engineered T Cells Revenue, 2017-2028
  6.3.2 US Engineered T Cells Market Size, 2017-2028
  6.3.3 Canada Engineered T Cells Market Size, 2017-2028
  6.3.4 Mexico Engineered T Cells Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Engineered T Cells Revenue, 2017-2028
  6.4.2 Germany Engineered T Cells Market Size, 2017-2028
  6.4.3 France Engineered T Cells Market Size, 2017-2028
  6.4.4 U.K. Engineered T Cells Market Size, 2017-2028
  6.4.5 Italy Engineered T Cells Market Size, 2017-2028
  6.4.6 Russia Engineered T Cells Market Size, 2017-2028
  6.4.7 Nordic Countries Engineered T Cells Market Size, 2017-2028
  6.4.8 Benelux Engineered T Cells Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Engineered T Cells Revenue, 2017-2028
  6.5.2 China Engineered T Cells Market Size, 2017-2028
  6.5.3 Japan Engineered T Cells Market Size, 2017-2028
  6.5.4 South Korea Engineered T Cells Market Size, 2017-2028
  6.5.5 Southeast Asia Engineered T Cells Market Size, 2017-2028
  6.5.6 India Engineered T Cells Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Engineered T Cells Revenue, 2017-2028
  6.6.2 Brazil Engineered T Cells Market Size, 2017-2028
  6.6.3 Argentina Engineered T Cells Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Engineered T Cells Revenue, 2017-2028
  6.7.2 Turkey Engineered T Cells Market Size, 2017-2028
  6.7.3 Israel Engineered T Cells Market Size, 2017-2028
  6.7.4 Saudi Arabia Engineered T Cells Market Size, 2017-2028
  6.7.5 UAE Engineered T Cells Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Autolus Limited
  7.1.1 Autolus Limited Corporate Summary
  7.1.2 Autolus Limited Business Overview
  7.1.3 Autolus Limited Engineered T Cells Major Product Offerings
  7.1.4 Autolus Limited Engineered T Cells Revenue in Global Market (2017-2022)
  7.1.5 Autolus Limited Key News
7.2 Bellicum Pharmaceuticals
  7.2.1 Bellicum Pharmaceuticals Corporate Summary
  7.2.2 Bellicum Pharmaceuticals Business Overview
  7.2.3 Bellicum Pharmaceuticals Engineered T Cells Major Product Offerings
  7.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue in Global Market (2017-2022)
  7.2.5 Bellicum Pharmaceuticals Key News
7.3 Cells Medica
  7.3.1 Cells Medica Corporate Summary
  7.3.2 Cells Medica Business Overview
  7.3.3 Cells Medica Engineered T Cells Major Product Offerings
  7.3.4 Cells Medica Engineered T Cells Revenue in Global Market (2017-2022)
  7.3.5 Cells Medica Key News
7.4 Elli Lilly and Company
  7.4.1 Elli Lilly and Company Corporate Summary
  7.4.2 Elli Lilly and Company Business Overview
  7.4.3 Elli Lilly and Company Engineered T Cells Major Product Offerings
  7.4.4 Elli Lilly and Company Engineered T Cells Revenue in Global Market (2017-2022)
  7.4.5 Elli Lilly and Company Key News
7.5 Gilead Sciences
  7.5.1 Gilead Sciences Corporate Summary
  7.5.2 Gilead Sciences Business Overview
  7.5.3 Gilead Sciences Engineered T Cells Major Product Offerings
  7.5.4 Gilead Sciences Engineered T Cells Revenue in Global Market (2017-2022)
  7.5.5 Gilead Sciences Key News
7.6 Juno Therapeutics
  7.6.1 Juno Therapeutics Corporate Summary
  7.6.2 Juno Therapeutics Business Overview
  7.6.3 Juno Therapeutics Engineered T Cells Major Product Offerings
  7.6.4 Juno Therapeutics Engineered T Cells Revenue in Global Market (2017-2022)
  7.6.5 Juno Therapeutics Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Engineered T Cells Major Product Offerings
  7.7.4 Novartis Engineered T Cells Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 Oxford Biomedica
  7.8.1 Oxford Biomedica Corporate Summary
  7.8.2 Oxford Biomedica Business Overview
  7.8.3 Oxford Biomedica Engineered T Cells Major Product Offerings
  7.8.4 Oxford Biomedica Engineered T Cells Revenue in Global Market (2017-2022)
  7.8.5 Oxford Biomedica Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Engineered T Cells Major Product Offerings
  7.9.4 Pfizer Engineered T Cells Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Precision Bioscience
  7.10.1 Precision Bioscience Corporate Summary
  7.10.2 Precision Bioscience Business Overview
  7.10.3 Precision Bioscience Engineered T Cells Major Product Offerings
  7.10.4 Precision Bioscience Engineered T Cells Revenue in Global Market (2017-2022)
  7.10.5 Precision Bioscience Key News
7.11 Redmile Group
  7.11.1 Redmile Group Corporate Summary
  7.11.2 Redmile Group Business Overview
  7.11.3 Redmile Group Engineered T Cells Major Product Offerings
  7.11.4 Redmile Group Engineered T Cells Revenue in Global Market (2017-2022)
  7.11.5 Redmile Group Key News
7.12 Seeking Alpha
  7.12.1 Seeking Alpha Corporate Summary
  7.12.2 Seeking Alpha Business Overview
  7.12.3 Seeking Alpha Engineered T Cells Major Product Offerings
  7.12.4 Seeking Alpha Engineered T Cells Revenue in Global Market (2017-2022)
  7.12.5 Seeking Alpha Key News
7.13 Unum Therapeutics
  7.13.1 Unum Therapeutics Corporate Summary
  7.13.2 Unum Therapeutics Business Overview
  7.13.3 Unum Therapeutics Engineered T Cells Major Product Offerings
  7.13.4 Unum Therapeutics Engineered T Cells Revenue in Global Market (2017-2022)
  7.13.5 Unum Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Engineered T Cells Market Opportunities & Trends in Global Market
Table 2. Engineered T Cells Market Drivers in Global Market
Table 3. Engineered T Cells Market Restraints in Global Market
Table 4. Key Players of Engineered T Cells in Global Market
Table 5. Top Engineered T Cells Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Engineered T Cells Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Engineered T Cells Revenue Share by Companies, 2017-2022
Table 8. Global Companies Engineered T Cells Product Type
Table 9. List of Global Tier 1 Engineered T Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Engineered T Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Engineered T Cells Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Engineered T Cells Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Engineered T Cells Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Engineered T Cells Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Engineered T Cells Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Engineered T Cells Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Engineered T Cells Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Engineered T Cells Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Engineered T Cells Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Engineered T Cells Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Engineered T Cells Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Engineered T Cells Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Engineered T Cells Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Engineered T Cells Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Engineered T Cells Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Engineered T Cells Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Engineered T Cells Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Engineered T Cells Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Engineered T Cells Revenue, (US$, Mn), 2023-2028
Table 30. Autolus Limited Corporate Summary
Table 31. Autolus Limited Engineered T Cells Product Offerings
Table 32. Autolus Limited Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 33. Bellicum Pharmaceuticals Corporate Summary
Table 34. Bellicum Pharmaceuticals Engineered T Cells Product Offerings
Table 35. Bellicum Pharmaceuticals Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 36. Cells Medica Corporate Summary
Table 37. Cells Medica Engineered T Cells Product Offerings
Table 38. Cells Medica Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 39. Elli Lilly and Company Corporate Summary
Table 40. Elli Lilly and Company Engineered T Cells Product Offerings
Table 41. Elli Lilly and Company Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 42. Gilead Sciences Corporate Summary
Table 43. Gilead Sciences Engineered T Cells Product Offerings
Table 44. Gilead Sciences Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 45. Juno Therapeutics Corporate Summary
Table 46. Juno Therapeutics Engineered T Cells Product Offerings
Table 47. Juno Therapeutics Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Engineered T Cells Product Offerings
Table 50. Novartis Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 51. Oxford Biomedica Corporate Summary
Table 52. Oxford Biomedica Engineered T Cells Product Offerings
Table 53. Oxford Biomedica Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Engineered T Cells Product Offerings
Table 56. Pfizer Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 57. Precision Bioscience Corporate Summary
Table 58. Precision Bioscience Engineered T Cells Product Offerings
Table 59. Precision Bioscience Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 60. Redmile Group Corporate Summary
Table 61. Redmile Group Engineered T Cells Product Offerings
Table 62. Redmile Group Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 63. Seeking Alpha Corporate Summary
Table 64. Seeking Alpha Engineered T Cells Product Offerings
Table 65. Seeking Alpha Engineered T Cells Revenue (US$, Mn), (2017-2022)
Table 66. Unum Therapeutics Corporate Summary
Table 67. Unum Therapeutics Engineered T Cells Product Offerings
Table 68. Unum Therapeutics Engineered T Cells Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Engineered T Cells Segment by Type in 2021
Figure 2. Engineered T Cells Segment by Application in 2021
Figure 3. Global Engineered T Cells Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Engineered T Cells Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Engineered T Cells Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Engineered T Cells Revenue in 2021
Figure 8. By Type - Global Engineered T Cells Revenue Market Share, 2017-2028
Figure 9. By Application - Global Engineered T Cells Revenue Market Share, 2017-2028
Figure 10. By Region - Global Engineered T Cells Revenue Market Share, 2017-2028
Figure 11. By Country - North America Engineered T Cells Revenue Market Share, 2017-2028
Figure 12. US Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Engineered T Cells Revenue Market Share, 2017-2028
Figure 16. Germany Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 17. France Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Engineered T Cells Revenue Market Share, 2017-2028
Figure 24. China Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 28. India Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Engineered T Cells Revenue Market Share, 2017-2028
Figure 30. Brazil Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Engineered T Cells Revenue Market Share, 2017-2028
Figure 33. Turkey Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Engineered T Cells Revenue, (US$, Mn), 2017-2028
Figure 37. Autolus Limited Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bellicum Pharmaceuticals Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cells Medica Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Elli Lilly and Company Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Gilead Sciences Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Juno Therapeutics Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Oxford Biomedica Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Precision Bioscience Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Redmile Group Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Seeking Alpha Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Unum Therapeutics Engineered T Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)